These results, together with a former report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the principle of targeting ACKR3 as a unique way to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant Conditions. These results advise that conolidine is https://rogerr936qpl9.birderswiki.com/user